The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study
Open accessAbstract
Background A low rate of blood pressure control has been reported in patients with chronic kidney disease (CKD). These data were derived from population-based samples with a low rate of CKD awareness.Study design Cross-sectional.Setting & participants Data from the baseline visit of the Chronic Renal Insufficiency Cohort (CRIC) Study (n = 3,612) were analyzed. Participants with an estimated glomerular filtration rate of 20-70 mL/min/1.73 m(2) were identified from physician offices and review of laboratory databases.Outcomes Prevalence and awareness of hypertension, treatment patterns, control rates, and factors associated with hypertension control.Measurements Following a standardized protocol, blood pressure was measured 3 times by trained staff, and hypertension was defined as systolic blood pressure > or =140 mm Hg and/or diastolic blood pressure > or =90 mm Hg and/or self-reported antihypertensive medication use. Patients' awareness and treatment of hypertension were defined using self-report, and 2 levels of hypertension control were evaluated: systolic/diastolic blood pressure <140/90 and <130/80 mm Hg.Results The prevalence of hypertension was 85.7%, and 98.9% of CRIC participants were aware of this diagnosis and 98.3% were treated with medications, whereas 67.1% and 46.1% had hypertension controlled to <140/90 and <130/80 mm Hg, respectively. Of CRIC participants with hypertension, 15%, 25%, 26%, and 32% were using 1, 2, 3, and > or =4 antihypertensive medications, respectively. After multivariable adjustment, older patients, blacks, and those with higher urinary albumin excretion were less likely, whereas participants using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were more likely to have controlled their hypertension to <140/90 and <130/80 mm Hg.Limitations Data were derived from a single study visit.Conclusions Despite almost universal hypertension awareness and treatment in this cohort of patients with CKD, rates of hypertension control were suboptimal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Difficulty controlling BP in late stages of CKD was also seen in CRIC (Chronic Renal Insufficiency Cohort), in which 88% of participants had stage 3 or 4 CKD.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [303]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials
Whelton, S. P., Chin, A., Xin, X., & He, J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00006 · Cited by 1,970
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241
Whelton, P. K., Appel, L. J., Espeland, M. A., Applegate, W. B., Ettinger, Jr., Kostis, J. B., Kumanyika, S., Lacy, C. R., Johnson, K. C., Folmar, S., et al. (1998) · JAMA · doi:10.1001/jama.279.11.839 · Cited by 1,200
Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Xin, X., He, J., Frontini, M. G., Ogden, L. G., Motsamai, O. I., & Whelton, P. K. (2001) · Hypertension · doi:10.1161/hy1101.093424 · Cited by 738
The Chronic Renal Insufficiency Cohort (CRIC) Study
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Čižman, B., Daugirdas, J. T., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 660
Self-citationPrevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United States
Coresh, J., Wei, G. L., McQuillan, G. M., Brancati, F., Levey, A. S., Jones, C. A., & Klag, M. J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1207 · Cited by 579
Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease
Muntner, P., He, J., Astor, B. C., Folsom, A. R., & Coresh, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080656 · Cited by 490
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–423 of 423
Konlan, K. D., Afaya, A., Anaman-Torgbor, J. A., Adedia, D., Todzro-Agudze, M., Biney, A. C., Kuug, A. K., Mumuni, H. I., Baiden, F., HyoJung, S., et al. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04594-y
History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease
Abramovitz, B., Hossain, A., Byfield, R. L., & Cohen, J. B. (2025) · Cardiology Clinics · doi:10.1016/j.ccl.2025.03.003
Kraft, L., & Latus, J. (2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21183-6.00003-9
DNA damage and repair in patients with early chronic kidney disease with or without type 2 diabetes
Sierra, J. A., Pazarín–Villaseñor, L., García-Sánchez, A., Cardona-Muñóz, E. G., Campos-Perez, W. Y., Martínez‐López, E., Campos-Bayardo, T. I., Román-Rojas, D., Gómez-Hermosillo, L. F., Casillas-Moreno, J., et al. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1601311
Wang, G., Bian, X., Luo, Q., Dong, J., Chen, W., Hao, Y., Wang, L., Xu, G., Yi, B., Liao, X., et al. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04495-4
Blutdruckzielwerte und pharmakologische Blutdruckkontrolle bei chronischer Nierenkrankheit
van der Giet, M. (2025) · Nephrologie aktuell · doi:10.1055/a-2624-1048
Anjajo, E. A., Workie, S. B., Tema, Z. G., Woldegeorgis, B. Z., & Bogino, E. A. (2024) · Figshare · doi:10.6084/m9.figshare.26586696
Huang, Y., Gan, X., Liang, H., Tang, S., Chen, J., & Shi, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1698418
Hypertension artérielle résistante et maladie rénale chronique : déterminants et risques associés
Kaboré, J. (2016) · theses.fr (ABES) · doi:10.70675/28f5ed83z9110z4f85z8b0fz6ea4e8d0aaae
de Pinho, N. A. (2019) · theses.fr (ABES) · doi:10.70675/f19e5556z67cbz4beazb36az4581696f0549
Volume extracellulaire : évolution et valeur pronostique au cours de la maladie rénale chronique
Faucon, A. (2020) · theses.fr (ABES) · doi:10.70675/e3fa10b5zefb2z456fzb3c3z25eec1870bad
Hùng, P. V., Yên, T. N., & Tràm, T. T. Y. T. K. V. H. (2025) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.119.2025.1035
Gupta, R., Jayaprakash, V., Asokan, A., & Mathew, G. G. (2026) · Revista Colombiana de Nefrología · doi:10.22265/acnef.13.1.946
Ammar, T. H. A., Ahmed, H. M., Mohammed, E. E. A., El‐Hariri, H. M., AbdelAleem, A., & Thomas, M. J. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11893-w
Optimizing Hypertension Control in CKD Through Collaborative Pharmacist Interventions
Yamada, M., Tiem, J. M. V., Hoskins, R., Kennelty, K. A., & Jalal, D. I. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001139
Vecchio, L. D., Comolli, S., Balafa, O. C., & Violo, L. (2026) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-032-29564-4_1
Briggs, A. H., Kohli-Lynch, C., Levy, A. R., Lin, Z.-Y., Chatterjee, S., Donato, B., & Kovesdy, C. (2026) · PharmacoEconomics - Open · doi:10.1007/s41669-026-00649-8
Mass spectrometry‐based urinary proteomic analysis in feline chronic kidney disease
Huang, J., Lourenço, B. N., Schmiedt, C. W., & Phillips, D. R. (2026) · Physiological Reports · doi:10.14814/phy2.71072
Ballegaard, E. L. F., Borg, R., Persson, F., Frost, K. H., Kampmann, J. D., Torp-Pedersen, C. T., & Carlson, N. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101539
Hessami, A., Gholami, F., Kheradmand, M., Alizadeh‐Navaei, R., & Moosazadeh, M. (2026) · Public Health Challenges · doi:10.1002/puh2.70385
Writers, A. M. (2013) · Drugs & Therapy Perspectives · doi:10.1007/s40267-013-0091-3
Metadata
- Authors
- Muntner, P., Anderson, A., Charleston, J., Chen, Z., Ford, V., Makos, G., O'Connor, A., Perumal, K., Rahman, M., Steigerwalt, S., Teal, V., Townsend, R., Weir, M., & Wright, J. T.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Pennsylvania (US)
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- University of Illinois Chicago (US)
- University Hospitals Cleveland Medical Center (US)
- St. John Medical Center (US)
- Case Western Reserve University (US)
- Corresponding author
- Muntner, Paul
- ORCID
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 55
- Issue
- 3
- Pages
- 441-451
- ISSN
- 0272-6386 (ISSN-L)
- PMC
- PMC2866514
- OpenAlex
- W2096512601
- Cited by
- 423
- References
- 16
- Citations by year
- 2026: 10 · 2025: 34 · 2024: 32 · 2023: 45 · 2022: 34 · 2021: 35 · 2020: 33 · 2019: 40 · 2018: 32 · 2017: 23 · 2016: 20 · 2015: 19 · 2014: 13 · 2013: 16 · 2012: 17
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Kidney Diseases (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (5U01DK06102, U01DK060990, 5U01 DK60980, T32DK007785, T32DK060455, K01DK064860, U01DK060984, U01DK060902, U01DK060980, U01DK060963, U01DK061021, U01DK061028)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- hypertension, chronic kidney disease, blood pressure control, hypertension awareness, antihypertensive medication use, ACE inhibitors, angiotensin receptor blockers, urinary albumin excretion, Chronic Renal Insufficiency Cohort Study, older adults, racial disparities
- MeSH terms
- Adult, Aged, Chronic Disease, Female, Humans, Hypertension, Kidney Diseases, Male, Middle Aged, Renal Insufficiency, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
